Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
about
Review article: a therapeutic update on dermatomyositis/polymyositis.Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Treatment of Clinically Amyopathic Dermatomyositis in adults: A Systematic Review.Treatment approaches to juvenile dermatomyositis.Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.Hydroxychloroquine: from malaria to autoimmunity.Review of dermatomyositis: establishing the diagnosis and treatment algorithm.Management of cutaneous dermatomyositis.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.[Paraneoplastic dermatomyositis revealing an undifferentiated nasopharyngeal carcinoma: about a case].Cutaneous clues to systemic disease.Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.Aminoquinoline antimalarial therapy in dermatomyositis-are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity?
P2860
Q33848574-A231240F-4ECB-4EF2-B05A-67B4BBF9A5BDQ34124740-E3F47002-4160-45EC-BE30-DFD5A7C986E0Q34349952-591095BC-72DB-4D02-AE5B-008CB43C321BQ34526090-E5498E6A-9663-4183-B5E4-1A276FF7336EQ35814405-8C8AA14B-1698-461E-8E23-BD5039F3ABB1Q36844843-538A7F36-0885-4B9E-AD9F-F3450FC81D09Q37827403-E0944590-E6C5-4F28-A5C0-CD9471A3F072Q38017740-79BDD6C3-9F32-4CB4-8F79-7DF7CAAD24EAQ38022271-09222C14-1B37-438B-ADA2-577B5C313576Q38221095-DBCC23BE-9CC9-4734-9434-18577965AE82Q38561490-6D75CEF4-E6AA-4B11-8A98-9E9B53C85CACQ41494480-04117716-C574-4781-BA0E-C759AF258E87Q41508452-6206A698-6DDE-43A9-8F78-FEB11CB7D506Q44750209-12036C2E-DC9A-4D5C-91E6-5A091A8F1B69Q47593445-9A62345F-B86A-45C0-A3E8-42E07B2E45C5Q47882674-4AA39C52-920B-4B86-BD36-F46223FB8B72Q51540185-7D43634C-198F-4929-8727-6C22EF4D3FE0Q55053285-0CDBF2E1-23BA-403B-B928-A8DD047DCD50
P2860
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
@en
type
label
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
@en
prefLabel
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
@en
P2093
P1476
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
@en
P2093
P304
P356
10.1016/S0190-9622(84)80263-7
P407
P577
1984-04-01T00:00:00Z